DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking patients: Correlations between tissues and detection by 32P-postlabelling and immunoassay

Erika Gyorffy, Lívia Anna, Zoltán Gyori, Judit Segesdi, J. Mináróvits, Ibolya Soltész, Szilárd Kostič, Atilla Csekeo, Miriam C. Poirier, B. Schoket

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Smoking is a major risk factor for lung cancer. This comparative study of smoking-related carcinogen-DNA adducts in pulmonary tissues and peripheral blood lymphocytes aims to further explore the primary DNA damaging processes by cigarette smoke in target and surrogate tissues. Samples of tumour and normal peripheral lung tissue, normal bronchial tissue and peripheral blood lymphocytes were obtained from a total of 85 lung cancer patients who underwent lung resection. Bulky DNA adducts were determined by 32P-postlabelling, and polycyclic aromatic hydrocarbon (PAH)-DNA adducts were detected by (±)-7β, 8α-dihydroxy-9α,10α -epoxy-7,8,9,10-tetrahydrobenzo[a]-pyrene-DNA chemiluminescence immunoassay (BPDE-DNA CIA) in smaller subsets of tissue samples subject to availability of DNA. Bulky DNA adduct levels ranged between 0.3 and 27.8 adducts/108 nucleotides (nt) with mean adduct levels between 2.8 and 11.5 adducts/108 nt. Mean PAH-DNA adduct levels were 2.6-6.2 adducts/108 nt. Significantly higher bulky DNA adduct levels were detected in smokers' lungs as compared with non-smokers' (P <0.02). PAH-DNA adduct levels appeared higher in the lungs of smokers compared with non-smokers but the difference was not significant. Lung tumour contained on average a 50% lower DNA adduct level compared with normal lung tissue. A statistically significant positive correlation was found between the DNA adduct levels of the corresponding tumour and normal lung tissue samples in both smokers and non-smokers using both methodologies. Bulky DNA adduct levels in normal lung and blood lymphocytes correlated significantly in non-smokers only (r = 0.55, P = 0.023). In lung tumour DNA samples there was a weak correlation between values obtained by 32P-postlabelling and by the BPDE-DNA immunoassay (r = 0.27, P = 0.054). However, with normal lung DNA samples, values obtained by the two assays did not correlate.

Original languageEnglish
Pages (from-to)1201-1209
Number of pages9
JournalCarcinogenesis
Volume25
Issue number7
DOIs
Publication statusPublished - Jul 2004

Fingerprint

DNA Adducts
Bronchi
Immunoassay
Smoking
Lymphocytes
Lung
Neoplasms
DNA
Nucleotides
Lung Neoplasms
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide
Luminescence
Smoke
Tobacco Products
Carcinogens

ASJC Scopus subject areas

  • Cancer Research

Cite this

DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking patients : Correlations between tissues and detection by 32P-postlabelling and immunoassay. / Gyorffy, Erika; Anna, Lívia; Gyori, Zoltán; Segesdi, Judit; Mináróvits, J.; Soltész, Ibolya; Kostič, Szilárd; Csekeo, Atilla; Poirier, Miriam C.; Schoket, B.

In: Carcinogenesis, Vol. 25, No. 7, 07.2004, p. 1201-1209.

Research output: Contribution to journalArticle

Gyorffy, Erika ; Anna, Lívia ; Gyori, Zoltán ; Segesdi, Judit ; Mináróvits, J. ; Soltész, Ibolya ; Kostič, Szilárd ; Csekeo, Atilla ; Poirier, Miriam C. ; Schoket, B. / DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking patients : Correlations between tissues and detection by 32P-postlabelling and immunoassay. In: Carcinogenesis. 2004 ; Vol. 25, No. 7. pp. 1201-1209.
@article{8aa5281e01244ac79b6436ed73b5fb66,
title = "DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking patients: Correlations between tissues and detection by 32P-postlabelling and immunoassay",
abstract = "Smoking is a major risk factor for lung cancer. This comparative study of smoking-related carcinogen-DNA adducts in pulmonary tissues and peripheral blood lymphocytes aims to further explore the primary DNA damaging processes by cigarette smoke in target and surrogate tissues. Samples of tumour and normal peripheral lung tissue, normal bronchial tissue and peripheral blood lymphocytes were obtained from a total of 85 lung cancer patients who underwent lung resection. Bulky DNA adducts were determined by 32P-postlabelling, and polycyclic aromatic hydrocarbon (PAH)-DNA adducts were detected by (±)-7β, 8α-dihydroxy-9α,10α -epoxy-7,8,9,10-tetrahydrobenzo[a]-pyrene-DNA chemiluminescence immunoassay (BPDE-DNA CIA) in smaller subsets of tissue samples subject to availability of DNA. Bulky DNA adduct levels ranged between 0.3 and 27.8 adducts/108 nucleotides (nt) with mean adduct levels between 2.8 and 11.5 adducts/108 nt. Mean PAH-DNA adduct levels were 2.6-6.2 adducts/108 nt. Significantly higher bulky DNA adduct levels were detected in smokers' lungs as compared with non-smokers' (P <0.02). PAH-DNA adduct levels appeared higher in the lungs of smokers compared with non-smokers but the difference was not significant. Lung tumour contained on average a 50{\%} lower DNA adduct level compared with normal lung tissue. A statistically significant positive correlation was found between the DNA adduct levels of the corresponding tumour and normal lung tissue samples in both smokers and non-smokers using both methodologies. Bulky DNA adduct levels in normal lung and blood lymphocytes correlated significantly in non-smokers only (r = 0.55, P = 0.023). In lung tumour DNA samples there was a weak correlation between values obtained by 32P-postlabelling and by the BPDE-DNA immunoassay (r = 0.27, P = 0.054). However, with normal lung DNA samples, values obtained by the two assays did not correlate.",
author = "Erika Gyorffy and L{\'i}via Anna and Zolt{\'a}n Gyori and Judit Segesdi and J. Min{\'a}r{\'o}vits and Ibolya Solt{\'e}sz and Szil{\'a}rd Kostič and Atilla Csekeo and Poirier, {Miriam C.} and B. Schoket",
year = "2004",
month = "7",
doi = "10.1093/carcin/bgh131",
language = "English",
volume = "25",
pages = "1201--1209",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "7",

}

TY - JOUR

T1 - DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking patients

T2 - Correlations between tissues and detection by 32P-postlabelling and immunoassay

AU - Gyorffy, Erika

AU - Anna, Lívia

AU - Gyori, Zoltán

AU - Segesdi, Judit

AU - Mináróvits, J.

AU - Soltész, Ibolya

AU - Kostič, Szilárd

AU - Csekeo, Atilla

AU - Poirier, Miriam C.

AU - Schoket, B.

PY - 2004/7

Y1 - 2004/7

N2 - Smoking is a major risk factor for lung cancer. This comparative study of smoking-related carcinogen-DNA adducts in pulmonary tissues and peripheral blood lymphocytes aims to further explore the primary DNA damaging processes by cigarette smoke in target and surrogate tissues. Samples of tumour and normal peripheral lung tissue, normal bronchial tissue and peripheral blood lymphocytes were obtained from a total of 85 lung cancer patients who underwent lung resection. Bulky DNA adducts were determined by 32P-postlabelling, and polycyclic aromatic hydrocarbon (PAH)-DNA adducts were detected by (±)-7β, 8α-dihydroxy-9α,10α -epoxy-7,8,9,10-tetrahydrobenzo[a]-pyrene-DNA chemiluminescence immunoassay (BPDE-DNA CIA) in smaller subsets of tissue samples subject to availability of DNA. Bulky DNA adduct levels ranged between 0.3 and 27.8 adducts/108 nucleotides (nt) with mean adduct levels between 2.8 and 11.5 adducts/108 nt. Mean PAH-DNA adduct levels were 2.6-6.2 adducts/108 nt. Significantly higher bulky DNA adduct levels were detected in smokers' lungs as compared with non-smokers' (P <0.02). PAH-DNA adduct levels appeared higher in the lungs of smokers compared with non-smokers but the difference was not significant. Lung tumour contained on average a 50% lower DNA adduct level compared with normal lung tissue. A statistically significant positive correlation was found between the DNA adduct levels of the corresponding tumour and normal lung tissue samples in both smokers and non-smokers using both methodologies. Bulky DNA adduct levels in normal lung and blood lymphocytes correlated significantly in non-smokers only (r = 0.55, P = 0.023). In lung tumour DNA samples there was a weak correlation between values obtained by 32P-postlabelling and by the BPDE-DNA immunoassay (r = 0.27, P = 0.054). However, with normal lung DNA samples, values obtained by the two assays did not correlate.

AB - Smoking is a major risk factor for lung cancer. This comparative study of smoking-related carcinogen-DNA adducts in pulmonary tissues and peripheral blood lymphocytes aims to further explore the primary DNA damaging processes by cigarette smoke in target and surrogate tissues. Samples of tumour and normal peripheral lung tissue, normal bronchial tissue and peripheral blood lymphocytes were obtained from a total of 85 lung cancer patients who underwent lung resection. Bulky DNA adducts were determined by 32P-postlabelling, and polycyclic aromatic hydrocarbon (PAH)-DNA adducts were detected by (±)-7β, 8α-dihydroxy-9α,10α -epoxy-7,8,9,10-tetrahydrobenzo[a]-pyrene-DNA chemiluminescence immunoassay (BPDE-DNA CIA) in smaller subsets of tissue samples subject to availability of DNA. Bulky DNA adduct levels ranged between 0.3 and 27.8 adducts/108 nucleotides (nt) with mean adduct levels between 2.8 and 11.5 adducts/108 nt. Mean PAH-DNA adduct levels were 2.6-6.2 adducts/108 nt. Significantly higher bulky DNA adduct levels were detected in smokers' lungs as compared with non-smokers' (P <0.02). PAH-DNA adduct levels appeared higher in the lungs of smokers compared with non-smokers but the difference was not significant. Lung tumour contained on average a 50% lower DNA adduct level compared with normal lung tissue. A statistically significant positive correlation was found between the DNA adduct levels of the corresponding tumour and normal lung tissue samples in both smokers and non-smokers using both methodologies. Bulky DNA adduct levels in normal lung and blood lymphocytes correlated significantly in non-smokers only (r = 0.55, P = 0.023). In lung tumour DNA samples there was a weak correlation between values obtained by 32P-postlabelling and by the BPDE-DNA immunoassay (r = 0.27, P = 0.054). However, with normal lung DNA samples, values obtained by the two assays did not correlate.

UR - http://www.scopus.com/inward/record.url?scp=3242794371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242794371&partnerID=8YFLogxK

U2 - 10.1093/carcin/bgh131

DO - 10.1093/carcin/bgh131

M3 - Article

C2 - 15001535

AN - SCOPUS:3242794371

VL - 25

SP - 1201

EP - 1209

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 7

ER -